Automate Your Wheel Strategy on HUM
With Tiblio's Option Bot, you can configure your own wheel strategy including HUM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HUM
- Rev/Share 1048.7169
- Book/Share 154.2177
- PB 1.551
- Debt/Equity 0.6807
- CurrentRatio 2.0242
- ROIC 0.049
- MktCap 28675488660.0
- FreeCF/Share 12.839
- PFCF 18.5362
- PE 22.2695
- Debt/Assets 0.2536
- DivYield 0.0148
- ROE 0.0728
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HUM | Goldman | -- | Sell | -- | $235 | Oct. 14, 2025 |
| Initiation | HUM | Evercore ISI | -- | In-line | -- | $295 | Sept. 22, 2025 |
| Upgrade | HUM | Raymond James | Market Perform | Outperform | -- | $315 | May 1, 2025 |
| Initiation | HUM | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | Oct. 11, 2024 |
| Upgrade | HUM | Bernstein | Market Perform | Outperform | -- | $308 | Oct. 8, 2024 |
| Downgrade | HUM | Jefferies | Buy | Hold | $519 | $253 | Oct. 7, 2024 |
| Downgrade | HUM | TD Cowen | Buy | Hold | $402 | $261 | Oct. 7, 2024 |
| Downgrade | HUM | Piper Sandler | Overweight | Neutral | $392 | $274 | Oct. 3, 2024 |
| Downgrade | HUM | Leerink Partners | Outperform | Market Perform | $400 | $250 | Oct. 2, 2024 |
| Downgrade | HUM | BofA Securities | Neutral | Underperform | $376 | $247 | Oct. 2, 2024 |
News
Should Value Investors Buy Humana (HUM) Stock?
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Humana Beats Q3 Earnings on Premium Growth, Updates 2025 View
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.
Read More
Humana Inc. (HUM) Q3 2025 Earnings Call Transcript
Published: November 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Humana Inc. ( HUM ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Lisa Stoner - Vice President of Investor Relations James Rechtin - President, CEO & Director Celeste Mellet - Chief Financial Officer David Dintenfass - President of Enterprise Growth George Renaudin - President of Insurance Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Justin Lake - Wolfe Research, LLC Stephen Baxter - Wells Fargo Securities, LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Kevin Fischbeck - BofA Securities, Research …
Read More
Humana's Q3 Beat Overshadowed By Weak 2025 EPS Guide And Rising Medical Costs
Published: November 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Humana receives a "Hold" rating due to fair valuation and ongoing underperformance versus the S&P 500. HUM's Q3 earnings beat expectations, but a light FY 2025 outlook and higher medical loss ratio pressured shares. Management aims to double Medicare Advantage margins by 2026, but faces headwinds from declining membership and regulatory changes.
Read More
Humana (HUM) Reports Q3 Earnings: What Key Metrics Have to Say
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Humana (HUM) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Humana (HUM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
Countdown to Humana (HUM) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Published: October 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Read More
Here's Why Humana (HUM) is a Strong Value Stock
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CarePlus Announces Medicare Advantage Plan Offerings for 2026
Published: October 22, 2025 by: Business Wire
Sentiment: Neutral
MIAMI--(BUSINESS WIRE)--CarePlus announces Medicare Advantage plan offerings for 2026.
Read More
UNH vs. HUM: Which Healthcare Stock is the Healthier Buy Now?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana's sharper Medicare focus, cost discipline and leaner structure position it ahead of UnitedHealth in the healthcare stock race.
Read More
Humana: Up 13% In A Week, Will HUM Stock Rally Continue?
Published: October 22, 2025 by: Forbes
Sentiment: Positive
Humana (NYSE: HUM) is currently riding a wave of positive momentum. The stock has been on a five-day continuous winning streak, delivering cumulative gains of 13% and adding approximately $4.0 billion in value.
Read More
Humana Announces 2026 Medicare Advantage Plans Designed with Veterans in Mind
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana announces 2026 Medicare Advantage plans designed with veterans in mind. Humana USAA Honor Giveback Plans elevate mental health support.
Read More
Humana and Providence Launch Innovative Data Exchange Collaboration to Advance Value-Based Care
Published: October 20, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Providence launch innovative data exchange collaboration to advance value-based care.
Read More
Are Investors Undervaluing Humana (HUM) Right Now?
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Humana (HUM) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
After losing some value lately, a hammer chart pattern has been formed for Humana (HUM), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Read More
Humana Loses Court Battle Over Medicare Advantage Ratings, Billions In Payments At Risk
Published: October 14, 2025 by: Benzinga
Sentiment: Negative
Humana Inc. (NYSE:HUM) lost a legal battle challenging cuts to its Medicare Advantage bonus payments, raising concerns over billions in potential revenue.
Read More
Humana loses challenge to 2025 Medicare Advantage ratings
Published: October 14, 2025 by: Reuters
Sentiment: Negative
A U.S. judge on Tuesday rejected Humana's bid to challenge the Centers for Medicare & Medicaid Services' 2025 ratings for its Medicare Advantage programs, which could cost the company millions in bonus payments from the government.
Read More
Why Humana (HUM) is a Top Value Stock for the Long-Term
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
HUMANA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: October 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Humana between July 27, 2022, to January 24, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Read More
Humana (HUM) Moves 4.0% Higher: Will This Strength Last?
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Is Humana (HUM) Stock Undervalued Right Now?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Humana Extends TailorCare Tie-Up to Enhance MA Member Health
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
HUM expands its TailorCare partnership to Dallas and Denver, aiming to boost MA member health and cut MSK-related costs.
Read More
2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.
Read More
Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana Inc. HUM, through its healthcare services businessCenterWell, has won court approval to acquire the assets of The Villages Health (“TVH”), a well-known medical group in Florida. The deal marks another step in Humana's effort to expand its senior-focused primary care platform and strengthen ties to its Medicare Advantage (MA) membership base.
Read More
Why Is Humana (HUM) Up 19.2% Since Last Earnings Report?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Read More
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members.
Read More
Here's Why Humana (HUM) is a Strong Value Stock
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Humana Announces New Agreements to Expand Specialized Care Programs for Patients Living with Musculoskeletal Conditions
Published: August 27, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana announces new agreements to expand specialized care programs for patients living with musculoskeletal conditions.
Read More
New Research from Humana Finds Value-Based Care Delivers Higher Quality of Care for Heart Failure Patients
Published: August 21, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Value-based care delivers a higher quality of care and better medication prescription adherence to evidence-based medicine for Medicare Advantage patients diagnosed with heart failure, according to findings released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its latest Value-Based Care Issue Brief. Heart failure continues to affect a growing number of Americans, with 11.4 million expected to be diagnosed by 2050. Patients with hea.
Read More
CNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana's strong Medicare Advantage growth and higher ROE give it an edge over Centene, which faces earnings pressure and OBBB Act headwinds.
Read More
About Humana Inc. (HUM)
- IPO Date 1981-12-31
- Website https://www.humana.com
- Industry Medical - Healthcare Plans
- CEO James A. Rechtin
- Employees 65680